Stockscreener 앱 받기
4.63
7.58%
-0.38
시간 외 거래:
4.60
-0.03
-0.65%
전일 마감가:
$5.01
열려 있는:
$4.77
하루 거래량:
846.49K
Relative Volume:
2.42
시가총액:
$244.43M
수익:
$17.63M
순이익/손실:
$-57.71M
주가수익비율:
-3.1284
EPS:
-1.48
순현금흐름:
$-60.45M
1주 성능:
-10.44%
1개월 성능:
+16.92%
6개월 성능:
+42.46%
1년 성능:
+2.66%
1일 변동 폭
$4.1325
$4.92
1주일 범위
$4.1325
$5.58
52주 변동 폭
$1.94
$6.2799
Scpharmaceuticals Inc Stock (SCPH) Company Profile
명칭
Scpharmaceuticals Inc
전화
617-517-0730
주소
25 BURLINGTON MALL ROAD, SUITE 203, BURLINGTON, MA
SCPH을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SCPH
Scpharmaceuticals Inc
|
4.63 | 277.69M | 17.63M | -57.71M | -60.45M | -1.48 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Scpharmaceuticals Inc Stock (SCPH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-09-07 | 개시 | Craig Hallum | Buy |
| 2022-12-01 | 개시 | Cowen | Outperform |
| 2022-10-21 | 재개 | Jefferies | Buy |
| 2022-10-11 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2022-08-02 | 개시 | Maxim Group | Buy |
| 2021-09-09 | 개시 | SVB Leerink | Mkt Perform |
| 2019-10-15 | 개시 | H.C. Wainwright | Buy |
| 2019-01-30 | 다운그레이드 | Leerink Partners | Outperform → Mkt Perform |
모두보기
Scpharmaceuticals Inc 주식(SCPH)의 최신 뉴스
How scPharmaceuticals Inc. stock performs during market volatilitySafe Entry Strategy with High Win Rate - Newser
scPharmaceuticals Inc. stock trendline breakdownDaily Technical Chart Pattern Analysis Report - Newser
What makes scPharmaceuticals Inc. stock price move sharplyTop Stock Picks with Forecast Accuracy - Newser
Strategies to average down on scPharmaceuticals Inc.Swing Gain Strategy with Entry Forecast - Newser
Using R and stats models for scPharmaceuticals Inc. forecastingTechnical Safety Zone Pattern Recognition - Newser
Analyzing scPharmaceuticals Inc. with multi timeframe chartsWealth Accumulation Outlook for Safe Investors - Newser
Identifying reversal signals in scPharmaceuticals Inc.Long Term Stock Growth Plan Suggestions - Newser
Is scPharmaceuticals Inc. forming a reversal patternSector Rotation Strategy for Smart Traders - Newser
Analyzing net buyer seller activity in scPharmaceuticals Inc.AI-Powered Stock Trend Movement Analysis - Newser
scPharmaceuticals Inc. Stock Performance After Earnings: Historical InsightsFree Fast Entry High Potential Stock Alerts - Newser
Building trade automation scripts for scPharmaceuticals Inc.Watchlist Summary for Active Day Traders - Newser
Chart based analysis of scPharmaceuticals Inc. trendsLoss Limitation Strategy Based on Analysis - Newser
ScPharmaceuticals anticipates meaningful Q3 nephrology contribution as FUROSCIX shipments rise 45% in Q2 2025 - MSN
Strong Financial Performance and Strategic Initiatives Justify Buy Rating for scPharmaceuticals - TipRanks
Can a trend reversal in scPharmaceuticals Inc. lead to recoveryTechnical Setup and Return Forecast Engine - Newser
What Fibonacci levels say about scPharmaceuticals Inc. reboundWatchlist Generator With Real-Time Entry - Newser
Sentiment analysis tools applied to scPharmaceuticals Inc.Investment Position Summary with Timeframe Forecast - Newser
Is scPharmaceuticals Inc. stock bottoming outFree Real Market Momentum Signal Generator - Newser
How to monitor scPharmaceuticals Inc. with trend dashboardsFree AI Powered High Return Stock Calls - Newser
Scpharmaceuticals 2025 Q2 Earnings Loss Narrows Despite Revenue Surge - AInvest
Using data tools to time your scPharmaceuticals Inc. exitTechnical Long-Term Outlook and Recap Guide - Newser
SCPH Revenue Up 99% - AOL.com
scPharmaceuticals Reports Strong Q2 2025 Growth - TipRanks
scPharmaceuticals Inc (SCPH) Q2 2025 Earnings Call Highlights: R - GuruFocus
scPharmaceuticals Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Promising Outlook for scPharmaceuticals: Buy Rating Supported by Strong Furoscix Demand and Strategic Growth Initiatives - TipRanks
scPharmaceuticals reports Q2 EPS (34c), consensus (30c) - TipRanks
scPharmaceuticals, Inc. (SCPH) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance
Scpharmaceuticals earnings missed by $0.05, revenue topped estimates - Investing.com Australia
Momentum divergence signals in scPharmaceuticals Inc. chartFree Weekly Potential Breakout Stock List - Newser
Using Bollinger Bands to evaluate scPharmaceuticals Inc.Smart Swing Picks with Confirmed Signals - Newser
What institutional flow reveals about scPharmaceuticals Inc.Weekly Movement Forecast With Chart Signals - Newser
Shareholders in scPharmaceuticals (NASDAQ:SCPH) are in the red if they invested five years ago - Yahoo Finance
What’s the recovery path for long term holders of scPharmaceuticals Inc.Strategy Chart for Real-Time Trade Flow - Newser
Will scPharmaceuticals Inc. rebound enough to break evenFree Long Hold Safe Return Strategy - Newser
Is It Too Early to Call Recovery in scPharmaceuticals Inc.Swing Trading Entry Signals Suggest Opportunity Zone - metal.it
Should you wait for a breakout in scPharmaceuticals Inc.Free Buy Low Sell High Stock Watch - Newser
Is scPharmaceuticals Inc. a candidate for recovery playFree Buy Alerts With Low Risk Confirmation - Newser
Why is scPharmaceuticals Inc. stock attracting strong analyst attentionFree Investment Timing Strategies - Jammu Links News
scPharmaceuticals Inc. Stock Analysis and ForecastNavigate the market with precision tools - Jammu Links News
What are analysts’ price targets for scPharmaceuticals Inc. in the next 12 monthsMaximize returns with timely market signals - Jammu Links News
What are the technical indicators suggesting about scPharmaceuticals Inc.Capitalize on market momentum for profits - Jammu Links News
What is scPharmaceuticals Inc. company’s growth strategyBuild wealth steadily with smart stock selection - Jammu Links News
Scpharmaceuticals Inc (SCPH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.24%
3.39%
자본화:
|
볼륨(24시간):